Clinical Trial Update: A Phase 2 Study of HB0017 in Psoriasis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HB0017 in psoriasis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• HB0017

Snippet

Sponsor: Huabo Biopharm Co., Ltd. | Conditions: Psoriasis (PsO) | Phase 2 | Status: RECRUITING